Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

ovarian mucinous adenocarcinoma - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

ovarian mucinous adenocarcinoma

MONDO:0005601

Also known as:mucinous adenocarcinoma of ovarymucinous adenocarcinoma of the ovarymucinous carcinoma of ovary

Find Clinical TrialsTrials

Overview

An invasive adenocarcinoma that arises from the ovary and is characterized by the presence of malignant epithelial cells that contain intracytoplasmic mucin. There is cellular atypia, increased layering of cells, complexity of glands, and papillary formations.

Clinical Trials7 registered

Diagnosis

Biomarker and diagnostic research for ovarian mucinous adenocarcinoma has been reported in the published literature.

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

7 clinical trials registered. Interventions under study include procedural interventions, drug therapy, biologic therapy, and other interventions. Pipeline includes 1 PHASE3, 3 PHASE2, 2 PHASE1. Research is primarily sponsored by academic and government institutions.

NCT ID	Title	Phase	Sponsor	Status
[NCT04739800](https://clinicaltrials.gov/study/NCT04739800)

Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 9:52 AM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

External Resources

Orphanet

European rare disease database

Orphanet:398961

GARD

Genetic and Rare Diseases Info Center

GARD:21651

Questions for Your Care Team

→Are any of the 7 active clinical trials a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

Research Type	Count	% of Total
Patient case studies	42	42%
Research summaries	21	21%
Disease patterns and progression	12	12%
Laboratory research	11	11%
Testing and diagnosis research	10	10%
Clinical study results	5	5%

ovarian mucinous adenocarcinoma

Overview

Diagnosis

Research Landscape

Medical References

External Resources

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Recent Publications